<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>centWave distinguishes low-abundance metabolite peaks from noise — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>centWave</strong>
  <span class="pred">&mdash;distinguishes&rarr;</span>
  <strong>low-abundance metabolite peaks from noise</strong>
</div>
<div class="entity-id">UNKNOWN:centwave &nbsp;&middot;&nbsp; UNKNOWN:low_abundance_peaks</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:100%;--color:#2ca02c"></div>
<div class="stat-row">
  <span>Class: Physical (10.0)</span>
  <span>Replicated: 1 paper</span>
  <span>Score: 172.00<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; DB Ref 0.5 &middot; Text Derived 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts &minus;0.5). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">SCORE BREAKDOWN</p>
<hr class="section-rule">
<div class="score-breakdown">Base weight: 10.00 (Physical, 1 paper)<br>Score from 20 citations: <strong>172.00</strong><br><span style="color:#888">2&times; extends (+24.00) &middot; 10&times; supports (+100.00) &middot; 8&times; applies (+48.00)</span><br>Neighbourhood: 173.42</div>


<p class="section-label">EVIDENCE CHAIN &middot; 1 source</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#2ca02c" title="Physical"></span><span>Physical</span><a href="https://doi.org/10.1186/1471-2105-9-504">10.1186/1471-2105-9-504</a> <a href="https://www.ebi.ac.uk/metabolights/MTBLS1430">MTBLS1430</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 20 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:100px"></span><span>10</span><span class="cite-subtotal">&middot; +100.00</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">iridoid glycosides — correlates_with → susceptibility to Hymenoscyphus fraxineus</span><span class="cite-claim-weight">+10.00</span><a href="../claim/90ffbb001a3b3f94.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">XCMS Online — predicts → dysregulated metabolic pathways</span><span class="cite-claim-weight">+10.00</span><a href="../claim/c6026f746cb75ad9.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">AMPK activation — inhibits → ferroptosis</span><span class="cite-claim-weight">+10.00</span><a href="../claim/271853c51354f589.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">energy stress — inhibits → lipid peroxidation</span><span class="cite-claim-weight">+10.00</span><a href="../claim/0fe5441e864355c6.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">AMPK — inhibits → polyunsaturated fatty acid biosynthesis</span><span class="cite-claim-weight">+10.00</span><a href="../claim/28905d04bc29ef6f.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">AMPK — inhibits → ferroptosis-associated renal ischaemia-reperfusion injury</span><span class="cite-claim-weight">+10.00</span><a href="../claim/35a7fb7421f3eff5.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">AMPK phosphorylation of acetyl-CoA carboxylase — decreases → polyunsaturated fatty acid biosynthesis</span><span class="cite-claim-weight">+10.00</span><a href="../claim/e4dac93c3d7bdf1d.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">AMPK inactivation — increases → ferroptosis</span><span class="cite-claim-weight">+10.00</span><a href="../claim/3ac429b0aeed6cb8.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">energy stress — activates → AMPK</span><span class="cite-claim-weight">+10.00</span><a href="../claim/bc1a4152879db56e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Fecal microbiota transplantation + anti-PD-1 (nivolumab/pembrolizumab) — causes → Grade 3 immune-related adverse events</span><span class="cite-claim-weight">+10.00</span><a href="../claim/86d04896338847ca.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:20px"></span><span>2</span><span class="cite-subtotal">&middot; +24.00</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">CAMERA — distinguishes → annotatable compounds in positive ion mode</span><span class="cite-claim-weight">+12.00</span><a href="../claim/86689c22200b723d.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">CAMERA — distinguishes → annotatable compounds in negative ion mode</span><span class="cite-claim-weight">+12.00</span><a href="../claim/08edae7a79a0409e.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:80px"></span><span>8</span><span class="cite-subtotal">&middot; +48.00</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Fraxinus excelsior genome — is_biomarker_for → ash dieback susceptibility</span><span class="cite-claim-weight">+6.00</span><a href="../claim/5680af315638532b.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">reduced susceptibility markers — distinguishes → Great Britain vs Denmark ash populations</span><span class="cite-claim-weight">+6.00</span><a href="../claim/edd18b02e3983a1f.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">energy stress — decreases → ATP</span><span class="cite-claim-weight">+6.00</span><a href="../claim/158e1ab6a7b7a1f7.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Fecal microbiota transplantation + anti-PD-1 (nivolumab/pembrolizumab) — treats → Advanced Melanoma</span><span class="cite-claim-weight">+6.00</span><a href="../claim/a99b5c4274ee8c27.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Fecal microbiota transplantation (healthy donor) — activates → anti-PD-1 efficacy</span><span class="cite-claim-weight">+6.00</span><a href="../claim/10c2d83d53315af2.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Donor microbiome similarity (over time) — predicts → Response to anti-PD-1 + FMT in advanced melanoma</span><span class="cite-claim-weight">+6.00</span><a href="../claim/d3343980e03bd79d.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Fecal microbiota transplantation (healthy donor) — increases → Immunogenic bacteria in gut microbiome</span><span class="cite-claim-weight">+6.00</span><a href="../claim/e91a9eeaa1eb3d12.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Fecal microbiota transplantation (healthy donor) — decreases → Deleterious bacteria in gut microbiome</span><span class="cite-claim-weight">+6.00</span><a href="../claim/9d99ac5cff2c8937.html">view &rarr;</a></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>f19d8306fcb6952c</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/UNKNOWN:centwave">UNKNOWN:centwave</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/UNKNOWN:low_abundance_peaks">UNKNOWN:low_abundance_peaks</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
